BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11961337)

  • 1. Relevance of underlying disease and bacterial vacA and cagA status on the efficacy of Helicobacter pylori eradication.
    Rudi J; Reuther S; Sieg A; Hoerner M; Stremmel W
    Digestion; 2002; 65(1):11-5. PubMed ID: 11961337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular detection of Helicobacter pylori vacA and cagA genes in gastric tissue specimens of patients with peptic ulcer disease and non-ulcer dyspepsia].
    Karaman M; Abacıoğlu H; Topalak OS; Simşek I
    Mikrobiyol Bul; 2011 Jan; 45(1):11-20. PubMed ID: 21341154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Helicobacter pylori in Georgian patients with dyspepsia.
    Olivares A; Buadze M; Kutubidze T; Lobjanidze M; Labauri L; Kutubidze R; Chikviladze D; Zhvania M; Kharzeishvili O; Lomidze N; Perez-Perez GI
    Helicobacter; 2006 Apr; 11(2):81-5. PubMed ID: 16579837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia.
    Erzin Y; Koksal V; Altun S; Dobrucali A; Aslan M; Erdamar S; Dirican A; Kocazeybek B
    Helicobacter; 2006 Dec; 11(6):574-80. PubMed ID: 17083380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori vacA genotypes and cagA gene in a series of 383 H. pylori-positive patients.
    Rudi J; Kuck D; Rudy A; Sieg A; Maiwald M; Stremmel W
    Z Gastroenterol; 2000 Jul; 38(7):559-64. PubMed ID: 10965552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review.
    Huang JQ; Zheng GF; Hunt RH; Wong WM; Lam SK; Karlberg J; Wong BC
    World J Gastroenterol; 2005 May; 11(18):2726-32. PubMed ID: 15884111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence attributes of Helicobacter pylori isolates & their association with gastroduodenal disease.
    Saxena A; Shukla S; Prasad KN; Ghoshal UC
    Indian J Med Res; 2011 May; 133(5):514-20. PubMed ID: 21623037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with Helicobacter pylori strains carrying babA2 and cagA is associated with an increased risk of peptic ulcer disease development in Iraq.
    Abdullah SM; Hussein NR; Salih AM; Merza MA; Goreal AA; Odeesh OY; Majed HS; Assafi MA; Hawrami K
    Arab J Gastroenterol; 2012 Dec; 13(4):166-9. PubMed ID: 23432983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between vacA subtypes, cytotoxin activity, and disease in Helicobacter pylori-infected patients from The Netherlands.
    Pan ZJ; van der Hulst RW; Tytgat GN; Dankert J; van der Ende A
    Am J Gastroenterol; 1999 Jun; 94(6):1517-21. PubMed ID: 10364017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treatment failure on the CagA EPIYA motif in
    Bustamante-Rengifo JA; Matta AJ; Pazos AJ; Bravo LE
    World J Gastroenterol; 2017 Mar; 23(11):1980-1989. PubMed ID: 28373764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment.
    van Doorn LJ; Schneeberger PM; Nouhan N; Plaisier AP; Quint WG; de Boer WA
    Gut; 2000 Mar; 46(3):321-6. PubMed ID: 10673291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cagA and vacA in strains of Helicobacter pylori from ulcer and non-ulcerative dyspepsia patients.
    Faundez G; Troncoso M; Figueroa G
    BMC Gastroenterol; 2002 Sep; 2():20. PubMed ID: 12223115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic type of Helicobacter pylori and the efficacy of eradication therapy].
    Parzecka M; Szaflarska-Popławska A; Mierzwa G; Gorzkiewicz M; Łuczak S; Grzybowski T
    Pol Merkur Lekarski; 2009 Feb; 26(152):105-9. PubMed ID: 19388513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori endemic and gastric disease.
    Siavoshi F; Malekzadeh R; Daneshmand M; Ashktorab H
    Dig Dis Sci; 2005 Nov; 50(11):2075-80. PubMed ID: 16240218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
    Tan HJ; Rizal AM; Rosmadi MY; Goh KL
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):110-5. PubMed ID: 16706821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of vacA alleles and cagA status of Helicobacter pylori in peptic ulcer disease and non-ulcer dyspepsia.
    Aydin F; Kaklikkaya N; Ozgur O; Cubukcu K; Kilic AO; Tosun I; Erturk M
    Clin Microbiol Infect; 2004 Dec; 10(12):1102-4. PubMed ID: 15606640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxin-associated gene A and vacuolating cytotoxin A in human isolates of Helicobacter pylori and their association with the clinical status of ulcer disease.
    Carattoli A; Pezzella C; Pietroiusti A; Galante A; Pezzotti P; Luzzi I
    Eur J Gastroenterol Hepatol; 2000 Nov; 12(11):1207-13. PubMed ID: 11111777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura.
    Ando T; Tsuzuki T; Mizuno T; Minami M; Ina K; Kusugami K; Takamatsu J; Adachi K; El-Omar E; Ohta M; Goto H
    Helicobacter; 2004 Oct; 9(5):443-52. PubMed ID: 15361084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant cagA/vacA genotypes and coinfection frequency of H. pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfection and severity of the diseases.
    Chen XJ; Yan J; Shen YF
    Chin Med J (Engl); 2005 Mar; 118(6):460-7. PubMed ID: 15788126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.